In order to thrive, precision medicine requires ‘novel business solutions’

Screen Shot at PM

Oncology currently leads the way in precision medicine advancements, but its forward progress is slowed by inefficiencies such as clinical trials that never reach completion due to lack of patients. This type of inefficiency can’t be solved by scientific enterprise alone; it requires novel business solutions.

We co-chair the Kraft Precision Medicine Accelerator at Harvard Business School. It aims to expedite the development and delivery of cancer treatments by improving the business processes that make them possible, such as direct-to-patient outreach and the aggregation and analysis of data. To improve these business processes, we need to approach them from a different perspective.

The accelerator uses “collective impact” to do this. Collective impact is a framework based on the idea that our society can address complex issues like cancer only when multiple, diverse stakeholders work together towards a shared goal.

Related article:  Viewpoint: Promise of genomics and precision medicine a 'wave of hype without substance'

Take investors. They can be vital to securing the funding required to create and conduct the clinical trials needed to deliver promising new therapies for a wide range of diseases.

This year, cancer will kill more than 600,000 Americans and nearly 9 million people around the world. To accelerate lifesaving innovations, we must abandon silos, embrace the power of collective impact, and work to make curing cancer everyone’s business.

Read full, original post: Precision medicine needs a business mindset in order to flourish

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend